Biomarkers in the drug development process: report from workshop discussions

Regul Toxicol Pharmacol. 2008 Nov;52(2):75-6. doi: 10.1016/j.yrtph.2008.05.001. Epub 2008 May 11.

Authors

Alain J van Gool¹, Per Spindler, Ernie Harpur, Denise Bounous, Klaus Olejniczak, Francy A J M van de Klundert, Bert Haenen

Affiliation

¹ Chair Organon Biomarker Platform, Target Discovery Unit Oss, NV Organon, Part of Schering-Plough Corporation, Molenstraat 110, 5340 BH Oss, The Netherlands.

PMID: 18556099
DOI: 10.1016/j.yrtph.2008.05.001

No abstract available

MeSH terms

Biomarkers, Pharmacological / metabolism*
Clinical Trials as Topic
Drug Design*
Drug Evaluation, Preclinical / methods
Drug Industry
Humans

Substances

Biomarkers, Pharmacological